You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The researchers found likely deleterious de novo tandem repeat mutations that were more common among individuals with autism spectrum disorder.
Two new studies of people with autism spectrum disorder indicate that mosaic mutations and copy number variants contribute to a person's risk for the condition.
Monozygotic twins differ on average by 5.2 early developmental mutations, and about 15 percent of them have a large number of mutational differences.
The researchers, who also performed whole-genome sequencing on 853 macaques, found new lineage-specific genes and expanded gene families in the monkeys.
Using data for more than 10,200 individuals with autism spectrum disorder and their family members, researchers delineated rare, inherited alterations and de novo changes.
In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.
A quasi-paired cohort analysis identified shifts in the detoxifying function of gut microbes from individuals with autism spectrum disorder.
The deal consists of cash, Bionano common stock, and assumption of liabilities. Bionano has also paid off $1.1 million loaned to Lineagen under the CARES act.
In Nature this week: researchers in Canada sequence the genome of the black mustard plant Brassica nigra, and more.
An analysis of whole-exome sequencing, brain gene expression, and health data suggests an autism subtype marked by dyslipidemia.
Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.
23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.
The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.
In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.